Conceptio › Archive › PLOS

PLOSopen access

Does randomization matter in rare disease clinical trials

Stephanie Wied et al.

PLOS · Papers · License: CC-BY

Open Source ↗

duchenne muscular dystrophy, nonsense mutation, duchenne muscular dystrophy, clinical trials, randomized controlled trials, medical risk factors

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Trends, patterns, determinants and socio-economic inequality of high-risk fertility behavior (HRFB) among Bangladeshi women: Evidence from Bangladesh Demographic and Health Surveys#646455
The impact of state- versus county-level mask mandates on economic activity during the COVID-19 pandemic#646458
The widening medication adherence gap#654079
The paradox of neglecting changes in behavior: How standard epidemic models misestimate both transmissibility and final epidemic size#654081

Record · ID 637004
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.